We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Abbott Completes Separation of Research-Based Pharmaceuticals Business

News   Jan 07, 2013

 
Abbott Completes Separation of Research-Based Pharmaceuticals Business
 
 
Advertisement
 

RELATED ARTICLES

Molecular Switch Turns on Brown Fat Energy Burn

News

An international research team have discovered how to activate brown fat in humans, which may lead to new treatments for type 2 diabetes and obesity.

READ MORE

Discovering the Strategies Tumor Cells Use To Evade Immune Attack

News

A new study has uncovered the strategies tumor cells use to evade immune system attack. The method developed for this work contributes to a better understanding of the "arms race" between immune defense and disease.

READ MORE

HDAC6 Halts the Spread of Triple-Negative Breast Cancer

News

The genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE